Need to know

FDA Recall of Blood Pressure Drug Worsens, More Drugs Included as Scary Details Revealed


As we reported last month, the FDA is recalling a common heart medication because it is contaminated with a carcinogen. The FDA widened the recall as part of their ongoing investigation.

The U.S. Food and Drug Administration is recalling drugs used to treat high blood pressure and heart failure that contain the active ingredient Valsartan. The U.S. FDA joins at least 22 other countries that are recalling drugs that include this drug.

Tests showed that there was N-nitrosodimethylamine (NDMA) in the recalled products. The FDA reported that NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.

NDMA is a chemical that is in a family of potent carcinogens. It has been used to make liquid rocket fuel, softeners, and lubricants. It can also be unintentionally produced through certain chemical reactions, and it is a byproduct of some pesticide manufacturing, the making of rubber tires, and fish processing.

“However, not all products containing valsartan are being recalled. The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured,” added the FDA.

The contaminated drugs were made at a lab in China. They were then repackaged by pharmaceutical companies worldwide.

The recall initially started on July 13. On July 27, the FDA released a new press release because they had discovered additional companies that had repackaged the contaminated drugs.

There is more, read here

Recommended for you

Comments are closed.